Navigation Links
ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
Date:10/1/2007

ST. LOUIS, Oct. 1 /PRNewswire/ -- ISTO Technologies, Inc., a privately held orthobiologics company, today announced that the United States Patent Office granted a key patent protecting the Company's core technology for cell-based cartilage repair: "Method for Chondrocyte Expansion with Phenotype Retention."

Currently, ISTO is developing products for cartilage regeneration and repair in knee joints and spinal discs using its cartilage cell expansion technology. Cartilage cells (chondrocytes) normally lose their native phenotype after serial expansion in vitro, and can no longer produce functional cartilage tissue. To circumvent this problem, ISTO's scientific team has developed a process for growing chondrocytes without the loss of phenotype, thereby providing a commercially viable number of cartilage cells for clinical applications.

"This is a significant patent for the Company. Our cell expansion technology serves as a platform for developing products for wide ranging medical needs," said Mitchell Seyedin, Ph.D., President & Chief Executive Officer, ISTO Technologies, Inc.

Cartilage regeneration is often called the "holy grail" of the orthopaedic industry because of its potential to restore function to damaged joints which otherwise have limited healing potential. Cartilage serves as a "shock absorber" protecting all joints including spinal discs from the wear and tear experienced during motion. Degeneration of cartilage in joints and spinal discs often leads to irreversible damage, causing pain and disability. Two of the most common causes of disability in adults, osteoarthritis and degenerative discs, are joint diseases affecting cartilage of the joints and spinal discs, respectively.

ISTO Technologies, Inc. is an orthobiologics company focusing on the development of differentiated products for sports medicine, spinal therapy and trauma. ISTO's products are intended for the repair and regeneration of damaged or injured cartilage and bone. For additional information, visit ISTO Technologies' website at http://www.istotech.com, or contact the company by phone at (314) 995-6049.


'/>"/>
SOURCE ISTO Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... PHILADELPHIA , Feb. 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immune system to find a better treatment for triple negative ... Start in France program. ... is an accelerator designed to help entrepreneurs grow their business ... was one of eight American companies selected to complete an ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):